X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - New Drug Approvals - 12/Aug 01:08

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure

Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class Indication expansion allows for the use of Furoscix in...

Articles similaires

Breakthrough WA treatment in removing fluid in the chest in cancer patients now set to help others

thewest.com.au - 06/Sep 18:00

A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...

Breakthrough WA treatment in removing fluid in the chest in cancer patients now set to help others

thewest.com.au - 06/Sep 18:00

A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...

Sorry! Image not available at this time

Regeneron, SNY Win FDA Approval for a Broader Dupixent Label

zacks.com - 17:19

REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.

Sorry! Image not available at this time

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 03/Sep 01:09

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

news.medical.net - 03/Sep 11:44

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

How Many People Have A-Fib? Three Times More Than We Thought

eurasiareview.com - 11/Sep 22:08

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...

Sorry! Image not available at this time

New pooled analysis published in The Lancet demonstrated reduced risk of combined CV death or worsening heart failure with semaglutide

drugs.com - 03/Sep 04:09

PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...

Sorry! Image not available at this time

Travere Gains 11% on Securing Full FDA Nod for Kidney Disease Drug

zacks.com - 09/Sep 15:58

The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...

Sorry! Image not available at this time

Travere Gains 11% on Securing Full FDA Nod for Kidney Disease Drug

zacks.com - 09/Sep 15:58

The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...